MARKET

PHAR

PHAR

Pharming Group N.V.
NASDAQ
13.18
-0.09
-0.68%
Opening 10:34 06/26 EDT
OPEN
13.05
PREV CLOSE
13.27
HIGH
13.30
LOW
13.05
VOLUME
2.44K
TURNOVER
--
52 WEEK HIGH
21.34
52 WEEK LOW
9.54
MARKET CAP
930.84M
P/E (TTM)
58.68
1D
5D
1M
3M
1Y
5Y
1D
Pharming: Profitable Core, Advancing Pipeline Underpin Buy Rating and Maintained $37 Price Target
TipRanks · 3d ago
Weekly Report: what happened at PHAR last week (0615-0619)?
Weekly Report · 4d ago
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?
NASDAQ · 06/15 11:59
Weekly Report: what happened at PHAR last week (0608-0612)?
Weekly Report · 06/15 10:30
Weekly Report: what happened at PHAR last week (0601-0605)?
Weekly Report · 06/08 10:25
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 06/04 14:21
Pharming Group held annual shareholder meeting; resolutions won up to 99.95% support
PUBT · 06/04 12:41
Pharming Wins FDA Review for Joenja Pediatric sNDA in APDS
TipRanks · 06/04 10:40
More
About PHAR
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Webull offers Pharming Group NV - ADR stock information, including NASDAQ: PHAR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAR stock methods without spending real money on the virtual paper trading platform.